Patient Insights: Severe psoriasis & eczemaHoward Chang has lived with severe psoriasis and atopic dermatitis for almost 40 years since childhood. Now a Share XPatient Insights: Severe psoriasis & eczemahttps://pharmaphorum.com/views-analysis-patients/patient-insights-severe-psoriasis-eczema/
Oncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and moreAZ and Daiichi Sankyo announced positive top-line results from the pivotal phase 2 DESTINY-Breast01 trial of trastuzumab deruxtecan, Share XOncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and morehttps://pharmaphorum.com/views-and-analysis/oncology-round-up-az-and-daiichi-score-key-trial-win-with-breast-cancer-antibody-and-more/
US healthcare reform scenarios and their impact on the systemIn an effort to control healthcare costs, provide healthcare to the uninsured and underinsured, and improve health outcomes, Share XUS healthcare reform scenarios and their impact on the systemhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/icon-us-healthcare-reform-scenarios/
Customer experience performance by pharmaceutical companiesThe need for pharmaceutical companies to meet or, ideally exceed, the expectations their customers have of them is Share XCustomer experience performance by pharmaceutical companieshttps://pharmaphorum.com/views-and-analysis/pharmaceutical-customer-experience-performance/
How pharma can excel in customer experiencePharmaceutical companies provide one of the, if not the, most important products to HCPs – the medical advances Share XHow pharma can excel in customer experiencehttps://pharmaphorum.com/views-and-analysis/pharma-customer-experience-excellence/
Spotlight on Understanding HCPsWhat do healthcare professionals (HCPs) want from pharmaceutical companies and how can the industry successfully engage with them? Share XViews & analysishttps://pharmaphorum.com/views-and-analysis/
Embracing next generation patient centricityPharma has largely accepted the value and importance of patient centricity – now it’s time to scale it Share XEmbracing next generation patient centricityhttps://pharmaphorum.com/patients/embracing-next-generation-patient-centricity/
VPAS 2024: What should industry consider next time?The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded Share XVPAS 2024: What should industry consider next time?https://pharmaphorum.com/views-analysis-market-access/vpas-2024-what-should-industry-consider-next-time/
AMR research and Matoke Pharma: the pharmaphorum podcastRe-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a Share XAMR research and Matoke Pharma: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/amr-research-matoke-pharma-podcast/
